Thibaud Koessler

629 total citations
16 papers, 22 citations indexed

About

Thibaud Koessler is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Thibaud Koessler has authored 16 papers receiving a total of 22 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Thibaud Koessler's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Thibaud Koessler is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Thibaud Koessler collaborates with scholars based in Switzerland, France and United States. Thibaud Koessler's co-authors include Juergen Weitz, Michael Krämer, Anke Reinacher‐Schick, Nikolas von Bubnoff, Gunnar Folprecht, Andrea Tannapfel, Christian Thiede, Lukas Weiß, Daniela E. Aust and Douglas I. Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Thibaud Koessler

7 papers receiving 22 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thibaud Koessler Switzerland 3 18 11 8 4 3 16 22
Tyler S. Twombly United States 2 15 0.8× 10 0.9× 12 1.5× 2 0.5× 6 2.0× 2 36
Simon Bird Australia 3 12 0.7× 12 1.1× 6 0.8× 4 1.0× 6 2.0× 3 39
Hiroya Taniguchi Japan 3 16 0.9× 12 1.1× 9 1.1× 7 1.8× 1 0.3× 3 17
César Rázuri Peru 3 10 0.6× 15 1.4× 11 1.4× 3 0.8× 4 1.3× 6 22
Christina Wu United States 3 12 0.7× 6 0.5× 4 0.5× 4 1.0× 2 0.7× 6 15
L. Layos Romero Spain 2 12 0.7× 10 0.9× 7 0.9× 4 1.0× 1 0.3× 4 16
Andrea Ruiz-Valdepeñas United Kingdom 3 10 0.6× 14 1.3× 5 0.6× 9 2.3× 3 1.0× 6 18
Abraham Tzou United States 1 13 0.7× 10 0.9× 4 0.5× 6 1.5× 5 1.7× 2 26
Mireia Sanchis Spain 3 16 0.9× 7 0.6× 3 0.4× 9 2.3× 5 1.7× 5 24
Matteo Papandrea Italy 2 17 0.9× 4 0.4× 13 1.6× 4 1.0× 3 1.0× 3 22

Countries citing papers authored by Thibaud Koessler

Since Specialization
Citations

This map shows the geographic impact of Thibaud Koessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thibaud Koessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thibaud Koessler more than expected).

Fields of papers citing papers by Thibaud Koessler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thibaud Koessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thibaud Koessler. The network helps show where Thibaud Koessler may publish in the future.

Co-authorship network of co-authors of Thibaud Koessler

This figure shows the co-authorship network connecting the top 25 collaborators of Thibaud Koessler. A scholar is included among the top collaborators of Thibaud Koessler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thibaud Koessler. Thibaud Koessler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bruyneel, Anne-Violette, et al.. (2025). Can a physical activity program improve functional capacity and fatigue in people with cancer? A retrospective analysis. BMC Sports Science Medicine and Rehabilitation. 17(1). 21–21.
2.
3.
Fivaz, Marc, et al.. (2025). Actionable mutations in pancreatic cancer: where targeted therapies are making a difference. BMJ Open Gastroenterology. 12(1). e001925–e001925.
4.
Corrò, Claudia, Frédéric Ris, G. Meurette, et al.. (2025). Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic Review. Clinical Colorectal Cancer. 24(4). 425–431.e1.
5.
Güller, Ulrich, Stefanie Hayoz, Daniel Horber, et al.. (2025). Adjuvant Aspirin Treatment in PIK3CA -Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial. Clinical Cancer Research. 31(15). 3142–3149. 1 indexed citations
6.
7.
Haberberger, James, Hanna Tukachinsky, Jonathan Keith Killian, et al.. (2025). Clinical Use of Liquid-Based Comprehensive Genomic Profiling in Gastrointestinal Stromal Tumors. Laboratory Investigation. 105(5). 104116–104116. 1 indexed citations
8.
9.
Koessler, Thibaud, et al.. (2025). Pancreatic Cancer: Epidemiology, Risk Factors, and Prevention. SHILAP Revista de lepidopterología. 5(3). 37–37.
10.
Güller, Ulrich, Stefanie Hayoz, Daniel Horber, et al.. (2024). 512O Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients: The phase III, prospective-randomized placebo-controlled multicenter SAKK 41/13 trial. Annals of Oncology. 35. S432–S432. 5 indexed citations
11.
12.
Koessler, Thibaud, et al.. (2023). Immunotherapy and Gastrointestinal Toxicities. Praxis. 112(3). 172–177.
13.
14.
Lenz, Heinz‐Josef, Eric Van Cutsem, Thibaud Koessler, et al.. (2022). Abstract CT507: ATP128 vaccine with ezabenlimab promotes antigen-specific immune responses in stage IV colorectal cancer in the KISIMA-01 phase 1b trial. Cancer Research. 82(12_Supplement). CT507–CT507.
15.
Koessler, Thibaud, Valérie Dutoit, Giacomo Puppa, et al.. (2020). A phase II study to evaluate safety and efficacy of neoadjuvant pembrolizumab and radiotherapy in localized MSS rectal cancer.. Journal of Clinical Oncology. 38(4_suppl). TPS272–TPS272. 2 indexed citations
16.
Folprecht, Gunnar, Anke Reinacher‐Schick, Andrea Tannapfel, et al.. (2020). Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217.. Journal of Clinical Oncology. 38(4_suppl). TPS273–TPS273. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tyler S. Twombly Breakdown of academic impact, for papers by Simon Bird Breakdown of academic impact, for papers by Hiroya Taniguchi Breakdown of academic impact, for papers by César Rázuri Breakdown of academic impact, for papers by Christina Wu Breakdown of academic impact, for papers by L. Layos Romero Breakdown of academic impact, for papers by Andrea Ruiz-Valdepeñas Breakdown of academic impact, for papers by Abraham Tzou Breakdown of academic impact, for papers by Mireia Sanchis Breakdown of academic impact, for papers by Matteo Papandrea
Rankless by CCL
2026